A Study of Golimumab in Participants With Active Psoriatic Arthritis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
The purpose of this study is to evaluate the efficacy of intravenously (administration of a fluid into the vein) administered golimumab 2 milligram per kilogram (mg/kg) in participants with active psoriatic arthritis (a chronic inflammatory arthritis that is associated with psoriasis).
Epistemonikos ID: b18fe1fb0ed983cb3b504b0bdee02272e61ea1a0
First added on: Feb 15, 2022